Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Al<sup>18</sup>F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging

Frederik CleerenLaboratory for Radiopharmaceutical research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, BelgiumJoan LecinaLaboratory for Radiopharmaceutical research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, BelgiumMuneer AhamedLaboratory for Radiopharmaceutical research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, BelgiumGeert RaesLaboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, BelgiumNick DevoogdtIn Vivo Cellular and Molecular Imaging Center, Vrije Universiteit Brussel, Brussels, BelgiumVicky CaveliersIn Vivo Cellular and Molecular Imaging Center, Vrije Universiteit Brussel, Brussels, BelgiumPaul McQuadeTranslational Biomarkers, Merck Research Laboratories, Merck & Co., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United StatesDaniel RubinsTranslational Biomarkers, Merck Research Laboratories, Merck & Co., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United StatesWenping LiTranslational Biomarkers, Merck Research Laboratories, Merck & Co., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United StatesAlfons VerbruggenLaboratory for Radiopharmaceutical research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, BelgiumCatarina XavierIn Vivo Cellular and Molecular Imaging Center, Vrije Universiteit Brussel, Brussels, BelgiumGuy BormansLaboratory for Radiopharmaceutical research, Department of Pharmacy and Pharmacology, University of Leuven, Leuven, Belgium
2017en
ABI

Аннотация

Positron emission tomography (PET) using radiolabeled biomolecules is a translational molecular imaging technology that is increasingly used in support of drug development. Current methods for radiolabeling biomolecules with fluorine-18 are laborious and require multistep procedures with moderate labeling yields. The Al 18 F-labeling strategy involves chelation in aqueous medium of aluminum mono[ 18 F]fluoride ({Al 18 F} 2+ ) by a suitable chelator conjugated to a biomolecule. However, the need for elevated temperatures (100-120 C) required for the chelation reaction limits its widespread use. Therefore, we designed a new restrained complexing agent (RESCA) for application of the AlF strategy at room temperature. Methods. The new chelator RESCA was conjugated to three relevant biologicals and the constructs were labeled with {Al 18 F} 2+ to evaluate the generic applicability of the one-step Al 18 F-RESCA-method. Results. We successfully labeled human serum albumin with excellent radiochemical yields in less than 30 minutes and confirmed in vivo stability of the Al 18 F-labeled protein in rats. In addition, we efficiently labeled nanobodies targeting the Kupffer cell marker CRIg, and performed PET studies in healthy and CRIg deficient mice to demonstrate that the proposed radiolabeling method does not affect the functional integrity of the protein. Finally, an affibody targeting HER2 (PEP04314) was labeled site-specifically, and the distribution profile of ()-[ 18 F]AlF(RESCA)-PEP04314 in a rhesus monkey was compared with that of [ 18 F]AlF(NOTA)-PEP04314 using whole-body PET/CT. Conclusion. This generic radiolabeling method has the potential to be a kit-based fluorine-18 labeling strategy, and could have a large impact on PET radiochemical space, potentially enabling the development of many new fluorine-18 labeled protein-based radiotracers.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0